Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Telesis Bio Inc (TBIO)

Telesis Bio Inc (TBIO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.9000 unch (unch) 04/24/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.9000 unch (unch) 13:52 ET
News & Headlines for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Telesis Bio: Q3 Earnings Snapshot

Telesis Bio: Q3 Earnings Snapshot

TBIO : 0.9000 (unch)
Telesis Bio: Q2 Earnings Snapshot

Telesis Bio: Q2 Earnings Snapshot

TBIO : 0.9000 (unch)
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

LEXINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines...

TBIO : 0.9000 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates TGRF, SIC, SAFM, TBIO; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / August 26, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: TGR Financial, Inc. (OTCQX:TGRF) concerning potential...

TGRF : 15.5500 (+1.83%)
SAFM : 204.00 (-2.51%)
TBIO : 0.9000 (unch)
SIC : 14.49 (+0.07%)
INVESTIGATION: Halper Sadeh LLP Investigates CMO, TBIO, SIC, SAFM; Shareholders are Encouraged to Contact the Firm

NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

TBIO : 0.9000 (unch)
SAFM : 204.00 (-2.51%)
CMO : 6.50 (+2.52%)
SIC : 14.49 (+0.07%)
INVESTIGATION: Halper Sadeh LLP Investigates SAFM, SBKK, SQ, TBIO; Shareholders are Encouraged to Contact the Firm

NEW YORK, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SAFM : 204.00 (-2.51%)
TBIO : 0.9000 (unch)
SBKK : 18.5800 (+1.03%)
SQ : 86.96 (+0.67%)
Translate Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update

-- Entered into a definitive agreement under which Sanofi will acquire, subject to customary  conditions to closing, all outstanding shares of Translate Bio with a goal of advancing deployment of mRNA...

TBIO : 0.9000 (unch)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates SQ, TBIO, OSBC, IKNX; Shareholders are Encouraged to Contact the Firm

NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

OSBC : 15.60 (+0.91%)
TBIO : 0.9000 (unch)
SQ : 86.96 (+0.67%)
IKNX : 33.90 (-0.29%)
Lifshitz Law Firm, P.C. Announces Investigation of HFC, OSBC, RYFL and TBIO

NEW YORK, Aug. 04, 2021 (GLOBE NEWSWIRE) --

OSBC : 15.60 (+0.91%)
TBIO : 0.9000 (unch)
HFC : 36.39 (+1.99%)
RYFL : 20.2500 (-1.22%)
TRANSLATE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Translate Bio - TBIO

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Translate Bio (NasdaqGS: TBIO) to Sanofi (NasdaqGS:...

TBIO : 0.9000 (unch)
SNY : 53.54 (+0.98%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective